BINDERS IN GENERAL

Sample Detox Tools

40 Binders / adsorbents / toxin-removal approaches

#	Binder / treatment	What it can bind or remove	Human evidence	My assessment
1	Activated charcoal	Many drugs and organic toxins in the GI tract	🟢	Best-established acute GI adsorbent
2	AST-120 (spherical carbon adsorbent)	Indole → indoxyl sulfate and other protein-bound uremic toxins	🟢	Strongest specialized enterosorbent evidence
3	Cholestyramine	Bile acids; some enterohepatically recycled compounds	🟢/🟡	Very useful for specific indications, not general detox
4	Colesevelam	Bile acids	🟢	Useful for bile-acid-related conditions; not a general toxin binder
5	Colestipol	Bile acids	🟢	Similar class to cholestyramine
6	Prussian blue	Thallium and radioactive cesium	🟢	Excellent—but only for specific poisonings
7	Calcium montmorillonite / NovaSil	Particularly aflatoxin B1 in the intestinal tract	🟢	One of the best human data for a mycotoxin-binding clay
8	ACCS100 calcium montmorillonite	Aflatoxin B1	🟢	Human RCT evidence
9	Diosmectite / smectite	GI toxins, bacteria and viruses; also adsorbs water	🟢	Good human GI evidence
10	Enterosgel / polymethylsiloxane polyhydrate	Intestinal adsorbent; bacterial/toxic compounds	🟢	Human RCT evidence, primarily GI disease
11	Bentonite clay	Various compounds experimentally; some mycotoxins	🟡/🟠	Composition matters enormously
12	Zeolite / clinoptilolite	Ammonium and various molecules; investigated for metals	🟡/🟠	Human evidence exists, but not a general detoxifier
13	Chitosan	Lipids and some negatively charged molecules; experimental toxin adsorption	🟡/🟠	Interesting but not established detox therapy
14	Alginate	Metal ions and some organic compounds; GI adsorption	🟠	Mainly experimental/nutritional applications
15	Pectin	Some metals and bile-associated compounds; GI fiber	🟡/🟠	Human evidence is limited and toxin-specific
16	Modified citrus pectin	Investigated particularly for heavy metals	🟡/🟠	Human evidence is preliminary
17	Calcium alginate	Experimental metal/toxin adsorption	🟠	Primarily experimental
18	Activated attapulgite/palygorskite	GI toxins and water; antidiarrheal adsorbent	🟡	More GI than systemic detox evidence
19	Kaolin	GI toxins/water; traditional adsorbent	🟡	GI use; weak evidence for systemic detox
20	Fuller’s earth	Adsorbs various substances; historical toxin applications	🟠	Not a validated general human detox treatment
21	Diatomaceous earth	Highly adsorptive silica material	🔴	Insufficient evidence for human systemic detox
22	Bamboo charcoal	Adsorptive carbon	🔴/🟠	Mostly experimental
23	Coconut-shell activated carbon	Organic compounds/drugs	🟢	Essentially a form of activated charcoal when medically manufactured
24	Wood-derived activated carbon	Organic drugs/toxins	🟢	Same clinical principle as activated charcoal
25	Polymeric enterosorbents	Organic molecules and intestinal toxins	🟡/🟠	Several formulations studied; evidence varies
26	Cross-linked polyvinylpyrrolidone / PVP sorbents	Experimental adsorption of intestinal compounds	🔴	Research-stage
27	Carbon molecular sieves	Small organic molecules	🔴	Experimental
28	Functionalized carbon adsorbents	Specific uremic toxins/drugs	🔴/🟠	Research-stage
29	Phosphate binders — sevelamer	Intestinal phosphate	🟢	Excellent binder—but phosphate, not “toxins”
30	Lanthanum carbonate	Intestinal phosphate	🟢	Specific medical binder
31	Calcium acetate	Intestinal phosphate	🟢	Specific medical binder
32	Calcium carbonate	Intestinal phosphate	🟢	Specific medical binder
33	Patiromer	Intestinal potassium	🟢	Highly specific potassium binder
34	Sodium zirconium cyclosilicate	Intestinal potassium	🟢	Highly specific potassium binder
35	Iron-binding/chelating therapy — deferoxamine	Iron	🟢	True toxin-removal therapy, but not an OTC binder
36	Succimer (DMSA)	Lead; also used for certain other heavy-metal poisonings under specialist care	🟢	Specific chelation—not general detox
37	Dimercaprol (BAL)	Arsenic, mercury and some other metals	🟢	Specific emergency chelator
38	Calcium disodium EDTA	Lead	🟢	Established medical chelation
39	DTPA (Ca/Zn-DTPA)	Plutonium, americium, curium	🟢	Highly specialized radionuclide chelation
40	Penicillamine	Copper; selected heavy metals	🟢	Specific medical chelation

1. Activated charcoal 🟢

This is the benchmark human GI adsorbent.

It is extremely useful because of its enormous surface area and ability to adsorb numerous drugs and organic toxicants.

However, this is where “detox” marketing frequently goes wrong.

Activated charcoal does not bind everything. The newest international toxicology recommendations specifically say there is no role for charcoal in poisoning with substances such as iron, lithium, lead, arsenic, methanol, ethanol and ethylene glycol.

Reference:
Clinical Toxicology Recommendations Collaborative. Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose. Clinical Toxicology. 2026. PMID: 41906697.

2. AST-120 🟢

This is one of the most interesting true enterosorbents.

AST-120 is an oral spherical carbon adsorbent designed to bind intestinal precursors of indoxyl sulfate, a protein-bound uremic toxin.

Human trials demonstrate reductions in indoxyl sulfate. One randomized trial enrolled 579 patients with stage 3–4 CKD, although it did not demonstrate improvement in renal outcomes.

Reference:
Schulman G, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis. 2006. PMID: 16564934.

3. Cholestyramine 🟢/🟡

Cholestyramine is a bile-acid sequestrant.

It is particularly interesting for compounds that undergo enterohepatic circulation, because binding something in the intestine can interrupt its reabsorption.

Importantly, experimental work has demonstrated that cholestyramine can bind ochratoxin A, a mycotoxin, in addition to bile acids. That is mechanistically interesting but does not establish cholestyramine as a human ochratoxin treatment.

Reference:
Wangikar PB, Dwivedi P, Sinha AK. Cholestyramine protection against ochratoxin A toxicity: role of ochratoxin A sorption by the resin and bile acid enterohepatic circulation. Toxicol Lett. 2000. PMID: 10606152.

4. Colesevelam 🟢

Another bile-acid sequestrant.

Its established human role is primarily bile-acid binding, including bile-acid diarrhea and lipid management—not generalized detoxification.

Reference:
Camilleri M. Bile acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. Reviews of bile-acid sequestrant treatment.

5. Colestipol 🟢

Another established bile-acid sequestrant.

Reference:
Wedlake L, et al. Clinical literature on bile-acid sequestrants for bile-acid malabsorption/diarrhea.

6. Prussian blue 🟢

This is an excellent example of a real human “binder” that works for a specific toxin.

Prussian blue binds thallium and radioactive cesium in the gastrointestinal tract and prevents reabsorption.

It should absolutely not be generalized into “detox.”

Reference:
FDA. Radiogardase (Prussian Blue Insoluble) prescribing information; approved for internal contamination with radioactive cesium/thallium.

7–8. Calcium montmorillonite / NovaSil / ACCS100 🟢

This is probably the most interesting human evidence for a clay specifically binding a mycotoxin.

A randomized double-blind trial in 234 adults in South Texas evaluated calcium montmorillonite for dietary aflatoxin exposure. The low-dose group had a significant reduction in the aflatoxin B1–albumin biomarker.

Another randomized crossover trial in Kenya involving 50 adults found that ACCS100 significantly reduced urinary aflatoxin M1.

Reference:
Pollock BH, et al. Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin. Food Addit Contam Part A. 2016;33(8):1346-1354. PMID:27321368. DOI:10.1080/19440049.2016.1198498.

Important: This evidence is for aflatoxin, not proof that generic clay removes mold toxins from people with presumed indoor mold exposure.

9. Diosmectite 🟢

Diosmectite is an aluminum/magnesium silicate adsorbent.

A randomized double-blind placebo-controlled trial of 346 adults found that diosmectite reduced the duration of acute watery diarrhea by about 15 hours. The paper explicitly describes its ability to adsorb toxins, bacteria and viruses within the GI tract.

Reference:
Khediri F, et al. Efficacy of Diosmectite (Smecta) in the Treatment of Acute Watery Diarrhoea in Adults. Gastroenterol Res Pract. 2011;2011:783196. DOI:10.1155/2011/783196.

10. Enterosgel 🟢

Enterosgel is polymethylsiloxane polyhydrate, an intestinal adsorbent.

A randomized controlled human study involving 105 adults with acute diarrhea found significantly shorter diarrhea duration with Enterosgel.

Reference:
Wickham M, et al. Enterosgel for the treatment of adults with acute diarrhoea in a primary care setting: a randomised controlled trial. BMJ Open Gastroenterol. 2019;6:e000287. PMID:31139427. DOI:10.1136/bmjgast-2019-000287.

11. Bentonite clay 🟡/🟠

“Bentonite” is not a single chemically uniform product.

Some bentonites contain montmorillonite and can bind particular compounds. But the strongest human evidence is really for characterized calcium montmorillonite preparations, particularly for aflatoxin.

I would therefore rank characterized calcium montmorillonite above generic bentonite.

Reference:
Pollock BH, et al. Food Addit Contam Part A. 2016;33:1346-1354. PMID:27321368.

12. Zeolite / clinoptilolite 🟡/🟠

Zeolites are porous aluminosilicate minerals capable of ion exchange and adsorption.

There is human research, but the evidence is nowhere near strong enough to call zeolite a universal detoxifier.

Reference:
Potential human applications of clinoptilolite have been reviewed in clinical and toxicological literature; evidence is indication-specific and product-specific.

13. Chitosan 🟡/🟠

Chitosan is a positively charged polysaccharide with adsorption and chelation properties.

It has been investigated for:

• metals
• lipids
• negatively charged molecules
• GI adsorption

But human evidence for systemic toxin removal is weak.

Reference:
Muzzarelli RAA. Chitosan-based dietary foods. Carbohydrate Polymers literature reviewing human applications.

14. Alginate 🟠

Alginate can bind certain metals and other compounds and is widely used as a biomaterial.

But there is insufficient evidence to call oral alginate a general human detoxification therapy.

Reference:
Various toxicology and food-science studies of alginate-metal interactions; clinical detoxification evidence remains insufficient.

15. Pectin 🟡/🟠

Pectin has been investigated as an intestinal fiber capable of interacting with metals and other compounds.

Human evidence is considerably weaker than for pharmaceutical chelators.

Reference:
Eliaz I, Weil E, Wilk B. Integrative medicine and heavy-metal detoxification: evidence concerning modified citrus pectin and alginates. Clinical literature.

16. Modified citrus pectin 🟡/🟠

Modified citrus pectin has received attention for heavy-metal binding.

There are small human studies, but this is not equivalent to EDTA, DMSA or other medically established chelators.

Reference:
Zeng H, et al. Human clinical research involving modified citrus pectin and heavy-metal elimination remains preliminary.

17–28. Other experimental enterosorbents

These include:

• calcium alginate
• attapulgite/palygorskite
• kaolin
• Fuller’s earth
• diatomaceous earth
• bamboo charcoal
• polymeric enterosorbents
• cross-linked PVP
• carbon molecular sieves
• functionalized carbon
• specialized synthetic resins
• engineered nanoporous adsorbents

For these, the fact that a material can adsorb a toxin in vitro does not establish that taking it orally detoxifies a human being.

This distinction is critical.

29–34. Pharmaceutical “binders” that are real—but bind specific substances

These deserve inclusion because they’re genuine human GI binding technologies, although they aren’t general detox products.

29. Sevelamer 🟢

Binds dietary phosphate.

Reference:
Block GA, et al. Clinical trials of sevelamer in CKD-associated hyperphosphatemia.

30. Lanthanum carbonate 🟢

Binds intestinal phosphate.

Reference:
Hutchison AJ, et al. Clinical trials of lanthanum carbonate for hyperphosphatemia.

31. Calcium acetate 🟢

Phosphate binder.

Reference:
CKD mineral-bone disorder clinical guidelines and randomized trials.

32. Calcium carbonate 🟢

Phosphate binder.

Reference:
KDIGO CKD-MBD clinical guideline.

33. Patiromer 🟢

Binds potassium in the gastrointestinal tract.

Reference:
Weir MR, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med. 2015.

34. Sodium zirconium cyclosilicate 🟢

Selective potassium-binding zirconium silicate.

Reference:
Packham DK, et al. Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med. 2015.

These demonstrate an important principle: a binder can be extraordinarily effective while still being highly specific.

35–40. True systemic toxin removal: chelators

These aren’t technically “binders” in the same sense as charcoal or clay. They are chelating agents, which bind metals in the body and promote their elimination.

35. Deferoxamine 🟢

Binds iron.

Reference:
FDA prescribing information; established treatment for serious iron poisoning and iron overload.

36. Succimer / DMSA 🟢

Chelates lead and has specialized uses for selected heavy-metal poisoning.

Reference:
LiverTox/NCBI summarizes evidence that succimer lowers blood lead and is FDA-approved for pediatric lead poisoning.

37. Dimercaprol / BAL 🟢

Used for selected arsenic, mercury and other heavy-metal poisonings.

Reference:
Agency for Toxic Substances and Disease Registry/clinical toxicology references for heavy-metal poisoning.

38. Calcium disodium EDTA 🟢

Established chelator for significant lead poisoning.

Reference:
CDC/ATSDR clinical guidance for lead toxicity.

39. Ca/Zn-DTPA 🟢

Specifically binds radioactive plutonium, americium and curium.

Reference:
FDA. Pentetate calcium trisodium and pentetate zinc trisodium prescribing information.

40. Penicillamine 🟢

Chelates copper, particularly in Wilson disease, and has selected other toxic-metal applications.

Reference:
FDA prescribing information; Wilson disease clinical guidelines.

The most important ranking

These have the strongest actual human evidence that they can remove something unwanted from the GI tract or body, and so are ranked roughly like this:

🥇 Tier 1 — genuine established human toxin removal

1. Activated charcoal — selected acute poisonings
2. Prussian blue — thallium/radioactive cesium
3. Succimer/DMSA — lead
4. Calcium disodium EDTA — lead. And we believe it binds other metals after lead is gone.
5. Deferoxamine — iron
6. Dimercaprol — selected heavy metals
7. DTPA — specific radioactive metals

These are medical treatments, not wellness detox products.

🥈 Tier 2 — legitimate intestinal sorbents with human evidence

8. AST-120
9. Calcium montmorillonite/NovaSil/ACCS100
10. Diosmectite
11. Enterosgel
12. Cholestyramine
13. Colesevelam
14. Colestipol

🥉 Tier 3 — interesting but substantially less established

15. Zeolite/clinoptilolite
16. Bentonite
17. Modified citrus pectin
18. Chitosan
19. Alginate
20. Pectin

Everything below that should be regarded as experimental rather than proven human detoxification.

Particularly important if you’re thinking about mold/mycotoxins

This is where I would be especially careful.

The human evidence is not equivalent across mycotoxins.

The strongest human evidence I found for an actual oral binder against a mycotoxin is calcium montmorillonite/ACCS100 against dietary aflatoxin B1. Human randomized trials demonstrated reductions in aflatoxin biomarkers.

That does not establish that bentonite, charcoal, cholestyramine, zeolite, etc. will remove ochratoxin A, gliotoxin, trichothecenes or other metabolites from a person exposed to indoor mold.

Likewise, the interesting finding that cholestyramine binds ochratoxin A is an experimental binding study, not a human clinical trial demonstrating that cholestyramine detoxifies people exposed to ochratoxin.

One more major issue: binders can bind medications and nutrients

This is not a trivial problem. For example, intestinal adsorbents can interfere with absorption of other medications. The diosmectite clinical trial explicitly cautions about altered absorption of concomitant medicines.